Key result
Cardiac amyloidosis often requires tissue sampling to determine the specific protein type for targeted treatment.
Why the study?
Cardiac amyloidosis presentation is often elusive leading to diagnostic delay, requiring tissue sampling and pathological typing of deposited proteins to direct specific treatment.
This review outlines the pathological features of cardiac amyloidosis, emphasizing the necessity of tissue sampling and protein typing to guide specific treatments.
Answers are grounded in this paper and cite their sources.
Tissue sampling remains essential for subtyping; leaves open validation of non-invasive alternatives in cardiac amyloidosis.
Cardiac amyloidosis is a well-known entity recently recognized as a common etiology of heart failure. This infiltrative disease is caused by the deposition of misfolded proteins within the heart. The most common types of cardiac amyloidosis result from fibrils composed of monoclonal immunoglobulin light chains or transthyretin. Clinical presentation is usually elusive, and this can result in diagnostic delay. Diagnosis can be reached with non-invasive methods, but it often requires tissue sampling with pathological analysis. It is fundamental to determine the type of protein being deposited in order to indicate the specific treatment. In this article, we review the main features of cardiac amyloidosis with a focus on different pathological presentations of this rare disorder.
No takes yet. Share an insight, caveat, or question.
Gaspari et al. (2022) conducted a review in Cardiac amyloidosis. Cardiac amyloidosis is an infiltrative disease often requiring tissue sampling and pathological analysis to determine the specific protein type for targeted treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: